35 results on '"Martignano, Filippo"'
Search Results
2. Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma
3. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
4. Analysis of Copy Number Variation in Urine: c-Myc Evaluation Using a Real-Time PCR Approach
5. Urinary RNA-based biomarkers for prostate cancer detection
6. Cell-Free DNA: An Overview of Sample Types and Isolation Procedures
7. Additional file 1 of Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
8. Additional file 6 of Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
9. Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
10. Additional file 1 of Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
11. Additional file 3 of Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
12. Evidence for RNA editing in the transcriptome of 2019 Novel Coronavirus
13. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
14. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2
15. Sequencing-based approaches for the study of Lung-related diseases
16. Carcinosarcoma of the prostate: case report with molecular and histological characterization
17. GSTP1 methylation in cancer: a liquid biopsy biomarker?
18. MOESM1 of Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach
19. Serum and Plasma Copy Number Detection Using Real-time PCR
20. Immunotherapy for Prostate Cancer: Where We Are Headed
21. Circulating androgen receptor and serum chromogranin A in castration-resistant prostate cancers (CRPC) patients treated with abiraterone and enzalutamide.
22. Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer
23. Cell-Free DNA Integrity Analysis in Urine Samples
24. The potential use of urine cell free DNA as a marker for cancer
25. Emerging mutations and functional changes of androgen receptor associated with treatment resistance in prostate cancer
26. Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach
27. Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in patients with different subtypes of breast cancer.
28. Circulating AR copy number and outcome to enzalutamide in patients with metastatic castration-resistant prostate cancer after docetaxel.
29. Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer
30. Impact of non-pulmonary visceral metastases in the prognosis and practice of metastatic testicular germ cell tumors
31. GSTP1Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications
32. Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients
33. GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications.
34. Modified Cas9-Guided Oxford Nanopore Technology Sequencing Uncovers Single and Multiple Transgene Insertion Sites in a Zebrafish Melanoma Model.
35. Cell-Free DNA: An Overview of Sample Types and Isolation Procedures.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.